advisorsecurities master

ALDXAldeyra Therapeutics, Inc.

CSNasdaq (XNAS)·USD

Identity

Security key
11563
Ticker
ALDX
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2014-05-02
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
ALDX

Detail

Enriched 2026-08-14 20:47

Market cap
$91,696,159.92
Shares outstanding (class)
60,326,421
Shares outstanding (weighted)
60,326,421
SIC
2834 PHARMACEUTICAL PREPARATIONS
Employees
6
Location
LEXINGTON, MA
Description

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma, and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data